|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang GJ, Rodriguez-Bigas MA, Skibber JM
and Moyer VA: Lymph node evaluation and survival after curative
resection of colon cancer: Systematic review. J Natl Cancer Inst.
99:433–441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ovrebo K and Rokke O: Extended lymph node
dissection in colorectal cancer surgery. Reliability and
reproducibility in assessments of operative reports. Int J
Colorectal Dis. 25:213–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greene FL: Current TNM staging of
colorectal cancer. Lancet Oncol. 8:572–573. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park IJ, Choi GS and Jun SH: Nodal stage
of stage III colon cancer: The impact of metastatic lymph node
ratio. Ann Surg Oncol. 100:240–243. 2009. View Article : Google Scholar
|
|
6
|
Ahmadi O, Stringer MD, Black MA and McCall
JL: Clinico-pathological factors influencing lymph node yield in
colorectal cancer and impact on survival: Analysis of New Zealand
cancer registry data. J Surg Oncol. 111:451–458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gonsalves WI, Kanuri S, Tashi T, Aldoss I,
Sama A, Al-Howaidi I, Ganta A, Kalaiah M, Thota R, Krishnamurthy J,
et al: Clinicopathologic factors associated with lymph node
retrieval in resectable colon cancer: A Veterans' Affairs Central
Cancer Registry (VACCR) database analysis. J Surg Oncol.
104:667–671. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wong KP, Poon JT, Fan JK and Law WL:
Prognostic value of lymph node ratio in stage III colorectal
cancer. Colorectal Dis. 13:1116–1122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong SL, Ji H, Hollenbeck BK, Morris AM,
Baser O and Birkmeyer JD: Hospital lymph node examination rates and
survival after resection for colon cancer. JAMA. 298:2149–2154.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feinstein AR, Sosin DM and Wells CK: The
will rogers phenomenon. Stage migration and new diagnostic
techniques as a source of misleading statistics for survival in
cancer. N Engl J Med. 312:1604–1608. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ceelen W, Van Nieuwenhove Y and Pattyn P:
Prognostic value of the lymph node ratio in stage III colorectal
cancer: A systematic review. Ann Surg Oncol. 17:2847–2855. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huh JW, Kim YJ and Kim HR: Ratio of
metastatic to resected lymph nodes as a prognostic factor in
node-positive colorectal cancer. Ann Surg Oncol. 17:2640–2646.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu YJ, Lin PC, Lin CC, Wang HS, Yang SH,
Jiang JK, Lan YT, Lin TC, Liang WY, Chen WS, et al: The impact of
the lymph node ratio is greater than traditional lymph node status
in stage III colorectal cancer patients. World J Surg.
37:1927–1933. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moug SJ, Saldanha JD, McGregor JR,
Balsitis M and Diament RH: Positive lymph node retrieval ratio
optimises patient staging in colorectal cancer. Br J Cancer.
100:1530–1533. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiu HB, Zhang LY, Li YF, Zhou ZW, Keshari
RP and Xu RH: Ratio of metastatic to resected lymph nodes enhances
to predict survival in patients with stage III colorectal cancer.
Ann Surg Oncol. 18:1568–1574. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rosenberg R, Engel J, Bruns C, Heitland W,
Hermes N, Jauch KW, Kopp R, Pütterich E, Ruppert R, Schuster T, et
al: The prognostic value of lymph node ratio in a population-based
collective of colorectal cancer patients. Ann Surg. 251:1070–1078.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arslan NC, Sokmen S, Canda AE, Terzi C and
Sarioglu S: The prognostic impact of the log odds of positive lymph
nodes in colon cancer. Colorectal Dis. 16:O386–O392. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aurello P, Petrucciani N, Nigri GR, La
Torre M, Magistri P, Tierno S, D'Angelo F and Ramacciato G: Log
odds of positive lymph nodes (LODDS): What are their role in the
prognostic assessment of gastric adenocarcinoma? J Gastrointest
Surg. 18:1254–1260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
La Torre M, Nigri G, Petrucciani N,
Cavallini M, Aurello P, Cosenza G, Balducci G, Ziparo V and
Ramacciato G: Prognostic assessment of different lymph node staging
methods for pancreatic cancer with R0 resection: PN staging, lymph
node ratio, log odds of positive lymph nodes. Pancreatology.
14:289–294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiu MZ, Qiu HJ, Wang ZQ, Ren C, Wang DS,
Zhang DS, Luo HY, Li YH and Xu RH: The tumor-log odds of positive
lymph nodes-metastasis staging system, a promising new staging
system for gastric cancer after D2 resection in China. PLoS One.
7:e317362012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Z, Xu Y, de Li M, Wang ZN, Zhu GL,
Huang BJ, Li K and Xu HM: Log odds of positive lymph nodes: A novel
prognostic indicator superior to the number-based and the
ratio-based N category for gastric cancer patients with R0
resection. Cancer. 116:2571–2580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vinh-Hung V, Verschraegen C, Promish DI,
Cserni G, Van de Steene J, Tai P, Vlastos G, Voordeckers M, Storme
G and Royce M: Ratios of involved nodes in early breast cancer.
Breast Cancer Res. 6:R680–R688. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Persiani R, Cananzi FC, Biondi A, Paliani
G, Tufo A, Ferrara F, Vigorita V and D'Ugo D: Log odds of positive
lymph nodes in colon cancer: A meaningful ratio-based lymph node
classification system. World J Surg. 36:667–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Hassett JM, Dayton MT and Kulaylat
MN: The prognostic superiority of log odds of positive lymph nodes
in stage III colon cancer. J Gastrointest Surg. 12:1790–1796. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Edge S, Byrd DR, Compton C, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th. Springer;
New York: 2010
|
|
26
|
Breiman L, Friedman J, Stone CJ and Olshen
RA: Classification and Regression Trees. Chapman and Hall/CRC; New
York: 1984
|
|
27
|
Chen SL, Steele SR, Eberhardt J, Zhu K,
Bilchik A and Stojadinovic A: Lymph node ratio as a quality and
prognostic indicator in stage III colon cancer. Ann Surg.
253:82–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hong KD, Lee SI and Moon HY: Lymph node
ratio as determined by the 7th edition of the American Joint
Committee on Cancer staging system predicts survival in stage III
colon cancer. J Surg Oncol. 103:406–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee HY, Choi HJ, Park KJ, Shin JS, Kwon
HC, Roh MS and Kim C: Prognostic significance of metastatic lymph
node ratio in node-positive colon carcinoma. Ann Surg Oncol.
14:1712–1717. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kobayashi H, Mochizuki H, Kato T, Mori T,
Kameoka S, Shirouzu K, Saito Y, Watanabe M, Morita T, Hida J, et
al: Lymph node ratio is a powerful prognostic index in patients
with stage III distal rectal cancer: A Japanese multicenter study.
Int J Colorectal Dis. 26:891–896. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nozoe T, Rikimaru T, Mori E, Okuyama T and
Takahashi I: Increase in both CEA and CA19-9 in sera is an
independent prognostic indicator in colorectal carcinoma. J Surg
Oncol. 94:132–137. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song YX, Gao P, Wang ZN, Tong LL, Xu YY,
Sun Z, Xing CZ and Xu HM: Which is the most suitable classification
for colorectal cancer, log odds, the number or the ratio of
positive lymph nodes? PLoS One. 6:e289372011. View Article : Google Scholar : PubMed/NCBI
|
